Abbott Laboratories Gains 12.7% in a Year: What's Driving the Stock?Zacks Investment Research • 03/17/25
Abbott Stock Could Be On The Verge Of A Breakout - Here's What Smart Money SeesSeeking Alpha • 03/17/25
Cagent Vascular Appoints Paul Wilson as Chief Commercial Officer to Drive Growth and Market ExpansionBusiness Wire • 03/04/25
Cadrenal Therapeutics Announces Collaboration Agreement with Abbott in Support of Pivotal Study of Tecarfarin in Patients with HeartMate 3™ LVADBusiness Wire • 03/04/25
Abbott (ABT) Increases Despite Market Slip: Here's What You Need to KnowZacks Investment Research • 02/21/25
Why We Chose Abbott Labs Stock Amid Tariff And DeepSeek VolatilityInvestors Business Daily • 02/07/25